Respiratory Syncytial Virus, Human
"Respiratory Syncytial Virus, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of PNEUMOVIRUS and an important cause of lower respiratory disease in infants and young children. It frequently presents with bronchitis and bronchopneumonia and is further characterized by fever, cough, dyspnea, wheezing, and pallor.
| Descriptor ID |
D018113
|
| MeSH Number(s) |
B04.820.455.600.670.600.750.730
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Respiratory Syncytial Virus, Human".
Below are MeSH descriptors whose meaning is more specific than "Respiratory Syncytial Virus, Human".
This graph shows the total number of publications written about "Respiratory Syncytial Virus, Human" by people in this website by year, and whether "Respiratory Syncytial Virus, Human" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 1 | 2 |
| 2013 | 3 | 0 | 3 |
| 2015 | 1 | 1 | 2 |
| 2017 | 0 | 2 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 4 | 1 | 5 |
| 2020 | 4 | 1 | 5 |
| 2021 | 7 | 0 | 7 |
| 2022 | 4 | 0 | 4 |
| 2023 | 13 | 1 | 14 |
| 2024 | 5 | 2 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Respiratory Syncytial Virus, Human" by people in Profiles.
-
Standardized Phylogenetic Classification of Human Respiratory Syncytial Virus below the Subgroup Level. Emerg Infect Dis. 2024 Aug; 30(8):1631-1641.
-
Early life respiratory syncytial virus disease-a preventable burden. Lancet Infect Dis. 2024 Aug; 24(8):794-795.
-
The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus. Nat Commun. 2024 Apr 10; 15(1):3083.
-
Change in Age profile of Respiratory Syncytial Virus disease over the course of annual epidemics: a multi-national study. J Infect. 2024 May; 88(5):106154.
-
Impact of Subgroup Distribution on Seasonality of Human Respiratory Syncytial Virus: A Global Systematic Analysis. J Infect Dis. 2024 Mar 01; 229(Supplement_1):S25-S33.
-
Infants Receiving a Single Dose of Nirsevimab to Prevent RSV Do Not Have Evidence of Enhanced Disease in Their Second RSV Season. J Pediatric Infect Dis Soc. 2024 Feb 26; 13(2):144-147.
-
Incidence and transmission of respiratory syncytial virus in urban and rural South Africa, 2017-2018. Nat Commun. 2024 01 02; 15(1):116.
-
Changes in the global hospitalisation burden of respiratory syncytial virus in young children during the COVID-19 pandemic: a systematic analysis. Lancet Infect Dis. 2024 Apr; 24(4):361-374.
-
Modeling the impact of COVID-19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa. Influenza Other Respir Viruses. 2023 Dec; 17(12):e13229.
-
TNFAIP3-interacting protein 1 polymorphisms and their association with symptomatic human respiratory syncytial virus infection and bronchiolitis in infants younger than one year from South Africa: A case-control study. Int J Infect Dis. 2023 Nov; 136:107-110.